iDose TR is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). iDose TR is the first-of-its-kind, long duration, anchored intracameral procedural pharmaceutical therapy for the treatment of OAG or OHT.

iDose® TR (travoprost intracameral implant) 75mcg, for intracameral administration. Initial U.S. Approval: 2001. iDose ® TR is a prostaglandin analog indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT) (1) Pigmentation: Increased pigmentation of the iris can occur.

Mar 26, 2024 · iDose TR is used to lower intraocular pressure (IOP) in patients who have ocular hypertension (OHT) or open-angle glaucoma (OAG). The increase in eye pressure in OAG can cause loss of peripheral vision followed by central field …

iDose: An Intraocular Drug-Eluting Delivery Device for Glaucoma A closer look at the device’s implantation, clinical trial findings, and outstanding questions.

Learn about iDose® TR (travoprost intracameral implant) 75 mcg—the convenient, FDA-approved treatment that helps lower eye pressure in most people with open-angle glaucoma or high eye pressure (ocular hypertension); discover the benefits of taking a …

iDose TR (travoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). iDose TR delivers continuous long-term prostaglandin analog therapy directly into the anterior chamber for IOP control with proven safety and patient tolerability.

Mar 25, 2025 · The iDose® TR is a breakthrough treatment for open-angle glaucoma, offering continuous eye pressure control with a one-time, microscopic implant. Instead of relying on daily eye drops, iDose® TR delivers medication directly inside the eye, 24/7. This can improve consistency, reduce side effects, and ease the burden of managing glaucoma.

Dec 14, 2023 · iDose TR (travoprost intracameral implant) is a long duration prostaglandin analog approved for a single administration and indicated for the reduction of intraocular pressure (IOP) in...

iDose TR can help a variety of patients keep glaucoma under control. Considerations include medical history, treatment experience, and adherence with current medication. Consider these types of patients within your practice who may be potential candidates for the iDose TRtreatment.

Dec 20, 2023 · iDose is a combination of a device and drug delivery. It's a titanium device with an anchor. It has a cap, a membrane, and inside is travoprost, a commonly used prostaglandin for lowering intraocular pressure.